Barclays Capital, the investment banking arm of UK bank Barclays, took a £1.3bn (€1.8bn) hit on credit-related securities linked to US sub-prime after it yielded to pressure from analysts and investors to reveal its exposure in advance of its trading statement.

Barclays Capital wrote down £500m for the third quarter and £800m in October, according to a statement from the bank today.